Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for reduction of organ dysfunction in sepsis
2018-000488-98Phase 4Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in sepsis and septic shock comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Reduction of organ dysfunction measured through SOFA score. Started Jan 2021; status: completed.
02
Drugs
esomeprazole
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on 2018-000488-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000488-98.